Cost analysis for CPT 81546 — Mrna gene analysis of 10,196 genes in fine needle aspiration thyroid specimen, reported as category result (e.g. benign, suspicious)
Average Medicare Payment
$3508.51
2023 data
Total Payments (2023)
$32.5M
Services (2023)
9.3K
Price Change (2021–2023)
-1.9%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2021 | $3577.20 | $28.2M | 7.9K | — |
| 2022 | $3534.54 | $29.8M | 8.4K | -1.2% |
| 2023 | $3508.51 | $32.5M | 9.3K | -0.7% |
The most expensive state pays 1.0x more than the cheapest for this procedure. CA averages $3508.51 vs CA at $3508.51.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| CA | $3508.51 | $32.5M | 9.3K | 1 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Veracyte, Inc. | Clinical Laboratory | CA | $32.5M | 9.3K | $3508.51 |
Based on the data, CPT 81546 shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Costs have decreased 1.9% since 2021. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.